Is 2C-E legal in Poland?

Also known as: eternity

Legal status

Controlled. Poland names this substance in its own national list. «2C-E» is entry lp. 13 in group IV-P of Załącznik nr 1, the psychotropic annex, with the designation «1-(2,5-dimetoksy-4-etylofenylo)-2-aminoetan». The placement is unusual and was checked twice: group IV-P is the tier that holds the benzodiazepines and zolpidem, and its sibling phenethylamines 2C-I and 2C-T-7 sit at group I-P instead. Article 33(1) of the 2005 Act allows group IV-P to be used for medical, industrial or research purposes.

Consequences if caught

Capital exposure: none. Poland has no death penalty, and the heaviest band the 2005 Act reaches for any conduct with this substance is a term of years. Possession is an offence under article 62(1) of the 2005 Act and the band there is up to three years. Where the quantity is considerable, article 62(2) sets a band of one year to ten years. In a case of lesser gravity article 62(3) provides instead for a fine, a restriction of liberty or up to one year. Article 62a lets proceedings be discontinued, even before the decision to open an investigation, where the quantity is insignificant and intended for the holder's own use and a penalty would be inexpedient. That is a power of the prosecutor and not an entitlement of the holder, so it is not decriminalisation. The possession band does not vary with the group, because article 62 is written against the categories of narcotic and psychotropic and not against the tier. The tier governs the lawful uses under article 33 rather than the penalty. Supply offences sit apart from possession. Article 56 punishes putting such a substance on the market with a fine and six months to eight years, and article 56(3) raises that to a fine and two years to twelve years where the quantity is considerable. Article 59(1) punishes supply for gain with one year to ten years.

If prescribed or medical

There is no authorised medicinal product with this substance in Poland, so no prescription route exists for it. The group IV-P placement permits a medical use in principle under article 33(1), but no authorised product exists.

Documentation

No personal import route exists, because a listed substance may be brought in only under the licensing chapter of the 2005 Act and not on a traveller's own account. The certificate issued under article 75 of the Convention implementing the Schengen Agreement is the route for a prescribed controlled medicine and does not reach a substance for which no prescription can be written. The group IV-P placement gives no lighter import position, because the licensing chapter of the 2005 Act governs entry for every listed substance alike.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Poland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.